Breaking News
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - New model more effective in predicting risk of opioid overdose than traditional models
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
General anesthesia in early infancy unlikely to have lasting effects on developing brains

General anesthesia in early infancy unlikely to have lasting effects on developing brains

image_pdfDownload PDFimage_print

One brief general anesthetic in early infancy is unlikely to be harmful to long-term neurodevelopment, but the safety of longer and repeated exposures remains unclear

A single hour of general anesthesia in early infancy—longer than is necessary to perform the most common types of minor surgeries in childhood—does not result in measurable neurodevelopmental or behavioral problems up to the age of 5 years, according to the first randomized trial of its kind involving 722 infants in seven countries, published in The Lancet.

The trial provides the strongest evidence to date that one brief exposure to anesthesia is safe in young children. Nevertheless, the authors caution that most (84%) study participants were male and more research is needed to confirm the findings in girls and children with multiple and prolonged exposure to anesthesia.

“Nearly half the general anesthetics given to infants are used for less than one hour, therefore our findings should reassure health professionals and the millions of parents whose young children undergo surgical or diagnostic procedures with anesthetic drugs worldwide every year,” says Professor Andrew Davidson, Murdoch Children’s Research Institute, Australia, who led the study.

“Parents and clinicians may want to delay necessary procedures—particularly in very young children. These findings mean children no longer need to be subjected to the potential medical and developmental risks of delaying surgery, and anesthetists do not have to avoid general anesthetics in favor of less well-established anesthetic techniques.”

The study is the first randomized trial to investigate whether exposure to general anesthesia in infancy (aged 60 weeks of postmenstrual age or younger), a time of high brain vulnerability, negatively impacts the growing brain at age 5.

During the first 3 years of life, around 1 in 10 children in developed countries—equating to millions of children every year—undergo surgical, medical, and diagnostic procedures under general anesthesia including hernia repair, tonsillectomy, imaging, and endoscopies.

For over a decade, the potential neurotoxicity of commonly used anesthetic drugs in children has been debated. In 2017, the US Food and Drug Administration warned that prolonged or repeated anesthesia in children younger than 3 years of age might affect brain development. However, this warning was based largely on animal studies which showed increased cell death in developing animals.

So far, research in humans has been limited to observational studies that have reported conflicting findings, and are unable to conclude whether anesthesia itself is causing problems, or if other factors such as the underlying medical conditions that make surgery necessary, or the surgical procedure itself, might be to blame.

To provide more evidence, the General Anaesthesia compared to Spinal anaesthesia (GAS) study recruited 722 children undergoing surgical repair of inguinal hernia (one of the most common operations of early childhood) at 28 hospitals in Australia, Italy, the USA, the UK, Canada, the Netherlands, and New Zealand between February 2007 and January 2013. Participants were randomly assigned to general anesthesia (363 children) or awake-regional (local) anesthesia (which does not cause brain injury in animal models; 359 children).

In 2016, interim results found that neurodevelopmental outcomes at age 2 years did not significantly differ between the general anesthesia and awake-regional groups.

Here, the researchers report the final results of the GAS trial at 5 years of age—a time when intelligence testing is strongly predictive of future achievement. Child psychologists used standard measures to assess the children’s IQ score, memory, attention, executive function (skills that help with memory, impulse control, and planning), and behavior.

Due to deviations from the treatment protocol (some children in the awake-regional group also had to be given a general anesthetic) and loss to follow up, only 205 of 363 children in the awake-regional group and 242 of 359 children in the general anesthesia group were included in the final analysis. The average duration of general anesthesia was 54 minutes.

Results showed no significant difference in IQ scores between the children exposed to general anesthesia (average IQ score 98.87) and awake-regional anesthesia (99.08), after adjusting for age at birth and country, and accounting missing data. There were no significant differences in a range of other tests of neurocognitive function.

The authors note several limitations, including that there were a substantial number of deviations from the treatment protocol in the awake-regional group because children had to be given general anesthesia, and a number of children were lost to follow up over the 5 years. They also point out that although several general anesthetics are commonly used in children, participants in the trial only received sevoflurane, which could limit the generalisability of the findings. Additionally, 5 years of age may be too young to detect some executive functions and social-emotional skills which do not develop until later in life.

Commenting on the implications of the findings, Dr James O’Leary from the University of Toronto in Canada says that the study provides the “strongest evidence to date” that a single, brief exposure to general anesthesia during infancy is not harmful to neurodevelopment. However, he cautions: “Adverse neurodevelopment in childhood results from interactions among multiple risk and protective factors, including health-care-related, genetic, familial, and environmental factors. Consequently, potential contributing factors other than general anesthesia (eg, type of surgery, sex [84% of study participants were male]) should be considered when interpreting and generalizing these findings. Perhaps most importantly, the study results cannot be extrapolated to children who undergo prolonged or repeated exposures to general anesthesia or receive multiple anesthetic drugs for the same surgical procedure…Whether anesthesia causes neurological injury in patients under these conditions remains to be established.”

Source:

https://www.thelancet.com/

Tagged with:

About author

Related Articles